cardiotoxicity
anthracyclin doxorubicin
DOX
effective
chemotherapeutic agent
DOX-induced
cardiac damage
results
formation
free radicals
DOX
Reactive oxygen species
cardiac
myocytes
cells
antioxidant defense system
semisynthetic flavonoid monohydroxyethylrutoside
monoHER
cardioprotection
DOX-induced
cardiotoxicity
radical scavenging
iron chelating
properties
half-life
monoHER
time interval
monoHER
DOX
influence
cardioprotective effect
monoHER
study
investigate
effect
